Spectrum Library

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.

Publication Date April 2019

Rituximab in neurological disease: principles, evidence and practice.

Publication Date November 2018

MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response

Publication Date July 2018

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing

Publication Date May 2018

NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness

Publication Date May 2018

Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies.

Publication Date April 2018

A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica.

Publication Date May 2018

Monitoring B-Cell Recovery Is Key in Treating Neurological Diseases With Rituximab

Publication Date May 2018

Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD.

Publication Date April 2018

Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation.

Publication Date March 2018

A severe, relapsing case of myelin oligodendrocyte glycoprotein IgG-associated CNS inflammation.

Publication Date February 2018

Rituximab before and during pregnancy A systematic review, and a case series in MS and NMOSD

Publication Date March 2018